TransMedics amends bylaws to incorporate SEC universal proxy rule requirements

TransMedics Group, Inc.

Board approved Second Amended and Restated Bylaws, effective November 2, 2022.
Amends director nomination procedures to require compliance with SEC Rule 14a-19 (universal proxy).
Shareholders must disclose proxy solicitation intent and notify company if they fail to comply with Rule.
No successor, substitute, or replacement nominees allowed after the nomination deadline.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

TransMedics Group, Inc.: Amended Bylaws to update procedural requirements for director nominations reflecting SEC's universal proxy rules and other administrative changes (effective 2022-11-02).

Change: bylaw amendment
Effective: 2022-11-02

Exact text from the filing

On November 2, 2022, the Board of Directors (the “Board”) of TransMedics Group, Inc. (the “Company”) approved the Company’s Second Amended and Restated Bylaws (as so amended and restated, the “Amended Bylaws”), effective as of such date.

View on SEC.gov

Browse all governance changes →

TransMedics Group, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-277952

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.